Salute H24

Senza mascherine previsti 300mila morti in Usa per coronavirus entro dicembre

Quasi 300.000 morti con coronavirus. E' questo il triste bilancio con cui rischiano di dover fare i conti entro il primo dicembre gli Stati Uniti, senza un uso diffuso e costante delle mascherine.

New IHME coronavirus COVID-19 Forecasts See Nearly 300,000 Deaths by December 1

America’s COVID-19 death toll is expected to reach nearly 300,000 by December 1; however, consistent mask-wearing beginning today could save about 70,000 lives, according to new data from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington’s School of Medicine. 

Anticorpi contro il coronavirus, parte la sperimentazione in USA

Al via una grande sperimentazione di fase 3 in Usa sugli anticorpi monoclonali contro Covid-19. I pazienti ricoverati con Covid-19 in alcuni ospedali selezionati in tutto il mondo potranno decidere di partecipare alla sperimentazione clinica avviata per testare la sicurezza e l'efficacia di questo potenziale nuovo trattamento per la malattia.

Coronavirus COVID-19 lockdown caused 50% global reduction in human-linked Earth vibrations

The lack of human activity during lockdown caused human-linked vibrations in the Earth to drop by an average of 50% between March and May 2020.

Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant

The Menarini Group and Radius Health, Inc. (Nasdaq: RDUS) announced today that the companies have entered into an exclusive global license agreement for development and commercialization of elacestrant.

Coronavirus, whole-town study reveals more than 40% of COVID-19 infections had no symptoms

The authors of the new research, from the University of Padova and at Imperial College London, published today in Nature, suggest asymptomatic or pre-symptomatic people are an important factor in the transmission of COVID-19. They also argue that widespread testing, isolating infected people, and a community lockdown effectively stopped the outbreak in its tracks. The town of Vò, with a population of nearly 3,200 people, experienced Italy’s first COVID-19 death on 21 February 2020.

Coronavirus, NIH halts clinical trial of hydroxychloroquine

A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus disease 2019 (COVID-19) has been stopped by the National Institutes of Health.

Coronavirus, NIH interrompe la sperimentazione clinica sull' idrossiclorochina

Uno studio clinico per valutare la sicurezza e l'efficacia dell'idrossiclorochina, per il trattamento degli adulti ricoverati in ospedale con la malattia di coronavirus 2019 (COVID-19) è stato interrotto dal National Institutes of Health (NIH). 

FDA approves pembrolizumab for adults and children with TMB-H solid tumors

On June 16, 2020, the Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA, Merck & Co., Inc.) for the treatment of adult and pediatric patients with unresectable or metastatic tumor mutational burden-high (TMB-H) [≥10 mutations/megabase (mut/Mb)] solid tumors, as determined by an FDA-approved test, that have progressed following prior treatment and who have no satisfactory alternative treatment options.

FDA grants accelerated approval to lurbinectedin for metastatic small cell lung cancer

On June 15, 2020, the Food and Drug Administration granted accelerated approval to lurbinectedin (ZEPZELCA, Pharma Mar S.A.) for adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.